Gsk (GSK) Other Operating Expenses (2009 - 2026)

Gsk (GSK) has 18 years of Other Operating Expenses data on file, last reported at -$57.7 million in Q3 2026.

• For the quarter ending Q3 2026, Other Operating Expenses changed N/A year-over-year to -$57.7 million; the trailing twelve-month figure through Sep 2026 stood at -$270.0 million (changed N/A YoY), and the FY2025 full-year result was $21.3 million, up 101.09% from the prior year.
• Other Operating Expenses was -$57.7 million for Q3 2026 at Gsk, up from -$265.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $890.3 million in Q4 2022 to a low of -$2.0 billion in Q4 2024.
• A 5-year average of -$149.3 million and a median of -$57.7 million in 2026 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 520.01% in 2022 and soared 1608.3% in 2026, its largest moves.
• Gsk's Other Operating Expenses stood at $890.3 million in 2022, then retreated by 19.84% to $713.7 million in 2023, then tumbled by 375.17% to -$2.0 billion in 2024, then soared by 92.07% to -$155.6 million in 2025, then soared by 62.9% to -$57.7 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$57.7 million in Q3 2026, -$265.7 million in Q2 2026, and $209.0 million in Q1 2026.